[HTML][HTML] Factors modulating COVID-19: A mechanistic understanding based on the adverse outcome pathway framework

LA Clerbaux, MC Albertini, N Amigo… - Journal of Clinical …, 2022 - mdpi.com
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows
that outcomes are markedly heterogeneous between patients. This requires identifying the …

[HTML][HTML] Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics

MA Alamri, A Altharawi, AB Alabbas… - Arabian Journal of …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has affected almost every country in the
world by causing a global pandemic with a high mortality rate. Lack of an effective vaccine …

An updated review on SARS-CoV-2 main Proteinase (MPro): protein structure and small-molecule inhibitors

DA Sabbah, R Hajjo, SK Bardaweel… - Current Topics in …, 2021 - ingentaconnect.com
Coronaviruses (CoVs) are enveloped positive-stranded RNA viruses with spike (S) protein
projections that allow the virus to enter and infect host cells. The S protein is a key virulence …

Exploration of novel lichen compounds as inhibitors of SARS-CoV-2 Mpro: ligand-based design, molecular dynamics, and ADMET analyses

A Gupta, N Sahu, AP Singh, VK Singh… - Applied Biochemistry …, 2022 - Springer
Abstract In the year 2019–2020, the whole world witnessed the spread of a disease called
COVID-19 caused by SARS-CoV-2. A number of effective drugs and vaccine has been …

Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors

S Ullrich, VM Sasi, MC Mahawaththa… - Bioorganic & Medicinal …, 2021 - Elsevier
Specific anti-coronaviral drugs complementing available vaccines are urgently needed to
fight the COVID-19 pandemic. Given its high conservation across the betacoronavirus genus …

The recent outbreaks of human coronaviruses: A medicinal chemistry perspective

T Pillaiyar, LL Wendt, M Manickam… - Medicinal research …, 2021 - Wiley Online Library
Coronaviruses (CoVs) infect both humans and animals. In humans, CoVs can cause
respiratory, kidney, heart, brain, and intestinal infections that can range from mild to lethal …

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

SG Katre, AJ Asnani, K Pratyush, NG Sakharkar… - Future Journal of …, 2022 - Springer
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a
novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors

Y Shimamoto, Y Hattori, K Kobayashi, K Teruya… - Bioorganic & medicinal …, 2015 - Elsevier
The design and evaluation of a novel decahydroisoquinolin scaffold as an inhibitor for
severe acute respiratory syndrome (SARS) chymotrypsin-like protease (3CL pro) are …

The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2

Z Jin, H Wang, Y Duan, H Yang - Biochemical and Biophysical Research …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an unprecedented global health …

In-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15 proteins of SARS-CoV-2

A Sharma, S Goyal, AK Yadav, P Kumar… - Journal of Biomolecular …, 2022 - Taylor & Francis
Abstract Novel Coronavirus or SARS-CoV-2 outbreak has developed a pandemic condition
all over the world. The virus is highly infectious and spreads by human to human local …